Questions around a case of in utero thrombosis in a premature child, concerning the management of anticoagulant treatments.

Authors :: Gerard D
Callies A
Simon L
Ternisien C
Prot-Labarthe S
Source :: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2024 Oct 25; Vol. 31 (6), pp. 588-591. Date of Electronic Publication: 2024 Oct 25.
Publication Year :: 2024
Abstract: We report the case of a preterm infant presenting a thrombosis, discovered on ultrasound at 22 weeks of gestational age and confirmed at birth following additional examinations. We describe the anticoagulant treatment of this patient by intravenous enoxaparin, tinzaparin and rivaroxaban, from questioning to practice.<br />Competing Interests: Competing interests: S P-L is an associate editor for EJHP.<br /> (© European Association of Hospital Pharmacists 2024. No commercial re-use. See rights and permissions. Published by BMJ.)

Subjects :: Humans
Infant, Newborn
Female
Pregnancy
Enoxaparin administration & dosage
Rivaroxaban administration & dosage
Rivaroxaban therapeutic use
Rivaroxaban adverse effects
Tinzaparin administration & dosage
Male
Anticoagulants administration & dosage
Anticoagulants therapeutic use
Anticoagulants adverse effects
Infant, Premature
Thrombosis drug therapy

Full Text Access

Tools